The Scientist

» antibiotics and disease/medicine

Most Recent

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

1 Comment

image: Antibiotic Affects Cow Dung

Antibiotic Affects Cow Dung

By | May 25, 2016

Researchers assess some of the downstream effects of treating livestock with a broad-spectrum antibiotic.

3 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Antibiotics From Scratch

Antibiotics From Scratch

By | May 18, 2016

Scientists develop a method for synthesizing hundreds of new macrolide antibiotics.

0 Comments

image: Genetic Connections Among Human Traits

Genetic Connections Among Human Traits

By | May 16, 2016

A study identifies genetic variants that are linked to multiple phenotypes.

0 Comments

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

Hordes of baby sea stars on the Pacific coast survived the summer and winter of 2015—promising news about populations that have been devastated by a wasting disease.

0 Comments

image: Narrow-Spectrum Antibiotic Could Spare the Microbiome

Narrow-Spectrum Antibiotic Could Spare the Microbiome

By | May 9, 2016

A drug that singles out Staphylococcus aureus leaves gut-dwelling microbiota largely intact, a mouse study shows.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS